Gromova, E. G., et al. «[Regulation of the indices of neuroendocrine status in
surgical patients with lung cancer using optimal doses of ascorbic acid].»
Not exact matches
In addition, the study showed that the 5 - year survival rate for selected older
patients with advanced
lung cancer who were treated
with surgical therapy was 29.9 % for Stage III and 26.7 % for Stage IV.
Among
lung cancer patients; suicide SMR was higher in males (SMR = 8.8), Asians (SMR = 13.7), widowed
patients (SMR = 11.6), older
patients (70 - 75 years; SMR = 12),
patients with undifferentiated tumors (SMR 8.6) or small cell
lung carcinoma (SCLC) histology (SMR = 11.2),
patients presenting
with metastatic disease (SMR = 13.9) and in
patients who refused to receive
surgical treatment (SMR = 13).
With the advancement of
surgical and radiation therapy strategies for stage 1 non-small-cell
lung cancer (NSCLC), more
patients are being treated, resulting in higher survival rates, according to a study published online today in The Annals of Thoracic Surgery.
City of Hope
patients have access to a wide variety of clinical trials looking into early - detection for
lung cancer, the newest chemotherapy treatments, targeted therapies and
surgical and radiation approaches — all
with the goal of helping extend life.